Alembic Limited (BOM:506235)

Market Cap	24.54B -12.7%
Revenue (ttm)	2.39B +16.5%
Net Income	3.19B +4.4%
EPS	12.42 +4.3%
Shares Out	256.78M
PE Ratio	7.69
Forward PE	n/a
Dividend	2.40 (2.44%)
Ex-Dividend Date	Aug 5, 2025

Volume	6,639
Average Volume	11,000
Open	99.05
Previous Close	99.21
Day's Range	98.21 - 99.44
52-Week Range	85.55 - 125.70
Beta	0.37
RSI	46.47
Earnings Date	Jan 29, 2026

About Alembic

Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredient; and engages in research and development activities. In addition, it is involved in power generation through co-genera...

• Industry: Real Estate
• Founded: 1907
• Employees: 256
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506235

Financial Performance

In fiscal year 2025, Alembic's revenue was 2.22 billion, an increase of 40.89% compared to the previous year's 1.57 billion. Earnings were 3.11 billion, an increase of 15.66%.